Schedule 13G ownership disclosure

HEPION PHARMACEUTICALS INC

Common Stock, par value $0.0001 per share · CUSIP: 426897104

Event date: 2025-01-22

Filing-level shares
1,060,883.00
Percent of class
9.99%
  • S.H.N. Financial Investments Ltd.

    Shares: 1,060,883.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001079973-25-000135
Form type
SCHEDULE 13G
Filer
Hepion Pharmaceuticals, Inc.
CIK
CIK 1583771
Filed
Jan 27, 2025
Reporting period
Jan 22, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub